CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −898 | $30.34 | $27K | 21,006 |
| 2025-12-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −1,394 | $30.85 | $43K | 19,612 |
| 2025-12-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −789 | $30.34 | $24K | 16,381 |
| 2025-12-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −1,225 | $30.85 | $38K | 15,156 |
| 2025-12-03 | Kaye Edward M. MD Director | Sale | −419 | $30.34 | $13K | 51,956 |
| 2025-12-03 | Kaye Edward M. MD Director | Sale | −651 | $30.85 | $20K | 51,305 |
| 2025-12-02 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −1,416 | $29.56 | $42K | 22,772 |
| 2025-12-02 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −868 | $30.14 | $26K | 21,904 |
| 2025-12-02 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −1,244 | $29.56 | $37K | 17,932 |
| 2025-12-02 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | −762 | $30.14 | $23K | 17,170 |
| 2025-12-02 | Kaye Edward M. MD Director | Sale | −661 | $29.56 | $20K | 52,780 |
| 2025-12-02 | Kaye Edward M. MD Director | Sale | −405 | $30.14 | $12K | 52,375 |
| 2025-12-01 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +12,357 | 24,188 | ||
| 2025-12-01 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −12,357 | 0 | ||
| 2025-12-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +11,981 | 19,176 | ||
| 2025-12-01 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −11,981 | 0 | ||
| 2025-12-01 | Kaye Edward M. MD Director | Option exercise · Restricted Stock Units | −4,317 | 0 | ||
| 2025-11-24 | Krainer Adrian R. Director | Sale 10b5-1 | −40,472 | $29.72 | $1.2M | 323,774 |
| 2025-11-14 | Krainer Adrian R. Director | Sale 10b5-1 | −19,790 | $26.61 | $527K | 384,928 |
| 2025-11-14 | Krainer Adrian R. Director | Sale 10b5-1 | −20,682 | $27.34 | $565K | 364,246 |
Page 8 of 13 · 256 trades